Prs105 - The Assessment the Health Utilities Index in Children With Severe Persistent Uncontrolled Asthma, Receiving Omalizumab

Value in Health - United Kingdom
doi 10.1016/j.jval.2018.09.2918
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Prs106 - The Assessment the Quality of Life in Children With Severe Persistent Uncontrolled Asthma, Receiving Omalizumab, by the Health Utilities Index and Standardised Paediatric Asthma Quality of Life Questionnaire(according to the Pediatric Registry)

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

Assessing the Quality of Life Using the Health Utilities Index Questionnaire in Children With Severe Persistent Asthma During the Treatment With Omalizumab

Pediatric pharmacology
2017English

The Long-Term Omalizumab Therapy in Children With Severe Persistent Uncontrolled Asthma: Evaluation of the Outcomes According to the Data of the Hospital Patient Registry

Pediatric pharmacology
2018English

Omalizumab in Patients With Severe Asthma and Persistent Sputum Eosinophilia

Journal of Allergy and Clinical Immunology
AllergyImmunology
2019English

First Experience With Omalizumab in a Child With Severe Persistent Asthma in Turkey: Case Report

Turkiye Klinikleri Journal of Medical Sciences
Medicine
2010English

Therapeutic Switch From Omalizumab to Mepolizumab in Patients With Uncontrolled Severe Eosinophilic Asthma: Treatment Effect by Prior Omalizumab Treatment Duration

Journal of Allergy and Clinical Immunology
AllergyImmunology
2019English

Lengthening Omalizumab Dosing Interval in Treatment of Moderate to Severe Persistent Asthma

Journal of Allergy and Clinical Immunology
AllergyImmunology
2019English

Determination of the Risk of Uncontrolled Persistent Bronchial Asthma in Children and Adolescents

Asthma and allergy
2019English

Daily Patient-Reported Health Status Assessment Improvements With Benralizumab for Patients With Severe, Uncontrolled Eosinophilic Asthma

Journal of Asthma and Allergy
ImmunologyPulmonaryAllergyRespiratory Medicine
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy